Gacad M A, Chen H, Arbelle J E, LeBon T, Adams J S
Cedars-Sinai Burns and Allen Research Institute, UCLA School of Medicine, Los Angeles, California 90048, USA.
J Biol Chem. 1997 Mar 28;272(13):8433-40. doi: 10.1074/jbc.272.13.8433.
Most genera of New World primates exhibit resistance to vitamin D. These monkeys harbor high circulating concentrations of the prohormone 25-hydroxyvitamin D and the active vitamin D hormone 1, 25-dihydroxyvitamin D. Previous work from this laboratory indicated that resistance is associated with the overexpression of a 60-65-kDa intracellular protein that binds vitamin D metabolites competitively. In the current studies 25-[3H]hydroxyvitamin D3 (25-OHD3) was used as a competitive ligand to investigate the ability of a number of small lipid molecules to interact with this intracellular vitamin D-binding protein (IDBP) in post-nuclear extracts of a prototypical lymphoblast cell line from the common marmoset, a vitamin D-resistant New World primate. Only those vitamin D metabolites with a hydroxyl moiety in the C-25 position were bound by IDBP. Disruption of the C-25 hydroxyl obviated binding, whereas more proximal alterations in the vitamin D side chain did not. Modifications in the A-ring of 25-hydroxylated vitamin D metabolites, most specifically hydroxylation of C-1, diminished but did not abolish ligand binding. Of more than two dozen other small lipid molecules examined, only the C-19 17-hydroxysteroids, 17beta-estradiol and testosterone, and the C-21 steroid progesterone were found to be capable of binding specifically to IDBP. Using a combination of physical and serial chromatographic techniques, we enriched IDBP 25-OHD3 binding activity 17,588-fold in extracts of B95-8 cells. Two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis of this purified fraction demonstrated a predominant 65-kDa molecular species with a pI approximately 4.5. Seven different peptide fragments were isolated from the 65-kDa protein, each possessing sequence similarity to the hsp-70 family of proteins. Ligand binding analyses confirmed that human inducibly expressed hsp-70-bound 25-OHD3 with approximately similar affinity ( approximately 10(-7) M) as did purified IDBP. In summary, these results suggest a novel action for the hsp-70 family of proteins as intracellular vitamin D- and gonadal steroid hormone-binding molecules.
新大陆灵长类动物的大多数属对维生素D具有抗性。这些猴子体内激素原25-羟基维生素D和活性维生素D激素1,25-二羟基维生素D的循环浓度很高。该实验室先前的研究表明,抗性与一种60 - 65 kDa的细胞内蛋白质的过表达有关,该蛋白质能竞争性结合维生素D代谢物。在当前的研究中,25-[³H]羟基维生素D3(25-OHD3)被用作竞争性配体,以研究一些小脂质分子与来自普通狨猴(一种对维生素D有抗性的新大陆灵长类动物)的原型淋巴母细胞系核后提取物中的这种细胞内维生素D结合蛋白(IDBP)相互作用的能力。只有那些在C-25位带有羟基部分的维生素D代谢物能被IDBP结合。C-25羟基的破坏消除了结合,而维生素D侧链中更靠近近端的改变则不会。25-羟基化维生素D代谢物A环的修饰,最特别的是C-1的羟基化,减少但并未消除配体结合。在检测的二十多种其他小脂质分子中,只有C-19 17-羟基类固醇、17β-雌二醇和睾酮以及C-21类固醇孕酮被发现能够特异性结合IDBP。使用物理和连续色谱技术相结合的方法,我们在B95-8细胞提取物中将IDBP 25-OHD3结合活性提高了17588倍。对该纯化组分进行二维十二烷基硫酸钠-聚丙烯酰胺凝胶电泳,显示出一种主要的65 kDa分子种类,其pI约为4.5。从65 kDa蛋白质中分离出七个不同的肽片段,每个片段与热休克蛋白70(hsp-70)家族的蛋白质具有序列相似性。配体结合分析证实,人诱导表达的hsp-70结合25-OHD3的亲和力(约10⁻⁷ M)与纯化的IDBP大致相似。总之,这些结果表明hsp-70家族的蛋白质作为细胞内维生素D和性腺类固醇激素结合分子具有一种新的作用。